These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 5285373

  • 1. Metabolism and absorption of L-3,4 dihydroxyphenylalanine in patients with Parkinson's disease.
    Bianchine JR, Calimlim LR, Morgan JP, Dujuvne CA, Lasagna L.
    Ann N Y Acad Sci; 1971 Jul 06; 179():126-40. PubMed ID: 5285373
    [No Abstract] [Full Text] [Related]

  • 2. Absorption and metabolism of L-dopa by the human stomach.
    Rivera-Calimlim L, Dujovne CA, Morgan JP, Lasagna L, Bianchine JR.
    Eur J Clin Invest; 1971 May 06; 1(5):313-20. PubMed ID: 5558777
    [No Abstract] [Full Text] [Related]

  • 3. Metabolism of levodopa in patients with Parkinson's disease. Radioactive and fluorometric assays.
    Morgan JP, Bianchine JR, Spiegel HE, Rivera-Calimlim L, Hersey RM.
    Arch Neurol; 1971 Jul 06; 25(1):39-44. PubMed ID: 5146410
    [No Abstract] [Full Text] [Related]

  • 4. [Dopa resorption and dopamin estimation in blood of patients with Parkinson's disease (author's transl)].
    Metzel E, Weitbrecht WU.
    Arch Psychiatr Nervenkr (1970); 1974 Jul 06; 219(3):231-7. PubMed ID: 4433233
    [No Abstract] [Full Text] [Related]

  • 5. Studies on the metabolism and excretion of L-3,4-dihydroxyphenylalanine (L-DOPA) in human beings by gas chromatography.
    Imai K, Sugiura M, Kubo H, Tamura Z, Oya K.
    Chem Pharm Bull (Tokyo); 1972 Apr 06; 20(4):759-64. PubMed ID: 5045616
    [No Abstract] [Full Text] [Related]

  • 6. Effect of amantadine on L-2-14C-dopa metabolism in parkinsonism.
    Peaston MJ, Bianchine JR, Messiha FS.
    Life Sci; 1973 Aug 16; 13(3):237-46. PubMed ID: 4750920
    [No Abstract] [Full Text] [Related]

  • 7. The biochemistry of catecholamines in relation to Parkinson's disease.
    Hinterberger H.
    Aust N Z J Med; 1971 May 16; 1():Suppl 1:14-8. PubMed ID: 5292808
    [No Abstract] [Full Text] [Related]

  • 8. Peripheral aromatic L-amino acids decarboxylase inhibitor in parkinsonism. II. Effect on metabolism of L-2- 14 C-dopa.
    Bianchine JR, Messiha FS, Hsu TH.
    Clin Pharmacol Ther; 1972 May 16; 13(4):584-94. PubMed ID: 5042372
    [No Abstract] [Full Text] [Related]

  • 9. Excretion of L-dopa and its metabolites in urine of Parkinson's disease patients receiving L-dopa therapy.
    Routh JI, Bannow RE, Fincham RW, Stoll JL.
    Clin Chem; 1971 Sep 16; 17(9):867-71. PubMed ID: 5571485
    [No Abstract] [Full Text] [Related]

  • 10. Metabolic interactions of pyridoxine, levodopa, and carbidopa in Parkinson's disease.
    Mars H.
    Trans Am Neurol Assoc; 1973 Sep 16; 98():241-5. PubMed ID: 4784941
    [No Abstract] [Full Text] [Related]

  • 11. Amino acid and dopa levels in plasma and urine from L-dopa-treated patients with Parkinson's disease.
    Hare TA, Vanna S, Beasley B, Chambers R, Vogel WH.
    J Lab Clin Med; 1971 Feb 16; 77(2):319-25. PubMed ID: 5540775
    [No Abstract] [Full Text] [Related]

  • 12. Development of a screening test for L-dopa and its metabolites in urine.
    Routh JI, Bannow RE.
    Clin Chem; 1971 Sep 16; 17(9):872-4. PubMed ID: 5571486
    [No Abstract] [Full Text] [Related]

  • 13. The effect of antacid administration on the absorption and metabolism of levodopa.
    Leon AS, Spiegel HE.
    J Clin Pharmacol New Drugs; 1972 Jul 16; 12(7):263-7. PubMed ID: 4483533
    [No Abstract] [Full Text] [Related]

  • 14. Interactions between levodopa and other drugs: significance in the treatment of Parkinson's disease.
    Bianchine JR, Sunyapridakul L.
    Drugs; 1973 Jul 16; 6(5):364-88. PubMed ID: 4787755
    [No Abstract] [Full Text] [Related]

  • 15. Biochemical investigations in patients with Parkinson's disease treated with L-dopa.
    Jequier E, Dufresne JJ.
    Neurology; 1972 Jan 16; 22(1):15-21. PubMed ID: 5061836
    [No Abstract] [Full Text] [Related]

  • 16. Catecholamine metabolism during oral administration of levodopa.
    Hinterberger H, Andrews CJ.
    Arch Neurol; 1972 Mar 16; 26(3):245-52. PubMed ID: 5061285
    [No Abstract] [Full Text] [Related]

  • 17. Kinetics of absorption and excretion of levodopa in dogs.
    Coutinho CB, Spiegel HE, Kaplan SA, Yu M, Christian RP, Carbone JJ, Symington J, Cheripko JA, Lewis M, Tonchen A, Crews T.
    J Pharm Sci; 1971 Jul 16; 60(7):1014-8. PubMed ID: 5115239
    [No Abstract] [Full Text] [Related]

  • 18. Variation of levodopa metabolism with gastrointestinal absorption site.
    Sandler M, Ruthven CR, Goodwin BL, Hunter KR, Stern GM.
    Lancet; 1974 Feb 16; 1(7851):238-40. PubMed ID: 4130247
    [No Abstract] [Full Text] [Related]

  • 19. Slowly absorbed L-dopa preparation in the treatment of parkinsonism.
    Laitinen LV.
    Acta Neurol Scand; 1973 Feb 16; 49(3):331-8. PubMed ID: 4747020
    [No Abstract] [Full Text] [Related]

  • 20. Dose-related alterations in metabolism of levodopa: possible mechanism for hypotensive effect.
    Kochar MS, Itskovitz HD, Sasse EA, Baker JD, Doumas BT.
    J Clin Pharmacol; 1974 Feb 16; 14(8):448-54. PubMed ID: 4851433
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.